Karachi: Hoechst Pakistan Limited, previously known as Sanofi-Aventis Pakistan Limited, announced its financial results for the first quarter ending March 31, 2025. The announcement followed a board meeting held on April 24, 2025, both at the company's head office and via video link.

The board approved the condensed interim financial statements, which were unaudited, but opted not to declare any cash dividends, bonus shares, or rights shares for the quarter. There were no additional entitlements or corporate actions recommended by the board. Furthermore, the company reported no price-sensitive information requiring disclosure for this period.

According to information available from the Pakistan Stock Exchange (PSX), the company's financial results for the quarter were detailed in annexures to the board's communication. These included both unconsolidated and consolidated statements, labeled Annexure 'A1 to A5' and Annexure 'B1 to B5,' respectively.

The quarterly report for Hoechst Pakistan Limited will be transmitted through the Pakistan Unified Corporate Action Reporting System (PUCARS) separately, adhering to the specified timeline. This report will also be accessible on the company's official website for stakeholders and interested parties.